News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
623,920 Results
Type
Article (54855)
Company Profile (105)
Press Release (568999)
Multimedia
Podcasts (186)
Webinars (27)
Section
Business (184646)
Career Advice (2501)
Deals (29915)
Drug Delivery (183)
Drug Development (74006)
Employer Resources (165)
FDA (16644)
Job Trends (12907)
News (288435)
Policy (31225)
Tag
2027 BioCapital Standard (1)
2027 BioMidwest Elite (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Biotech Beach Standard (2)
2027 Genetown Elite (2)
2027 Genetown Standard (4)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (6)
Academia (2747)
Academic (1)
Accelerated approval (65)
ADA (47)
Adcomms (44)
Allergies (198)
Alliances (41211)
ALS (240)
Alzheimer's disease (2012)
Antibody-drug conjugate (ADC) (553)
Approvals (17026)
Artificial intelligence (792)
ASCO (316)
Autoimmune disease (375)
Automation (60)
Bankruptcy (323)
Best Places to Work (9844)
BIO (71)
Biologics (2)
BIOSECURE Act (23)
Biosimilars (263)
BioSpace Insights (150)
Biotechnology (67)
Bladder cancer (219)
Brain cancer (80)
Breast cancer (817)
Cancer (6566)
Cardiovascular disease (599)
Career advice (2141)
Career pathing (54)
CAR-T (369)
CDC (77)
Celiac Disease (2)
Cell therapy (1013)
Cervical cancer (55)
Clinical research (65314)
Collaboration (2213)
Commercialization (9)
Company closure (8)
Compensation (1647)
Complete response letters (121)
COVID-19 (2856)
CRISPR (124)
C-suite (1314)
Cystic fibrosis (161)
Data (8822)
Decentralized trials (3)
Denatured (45)
Depression (202)
Dermatology (116)
Diabetes (687)
Diagnostics (6436)
Digital health (60)
Diversity (9)
Diversity, equity & inclusion (43)
Drug discovery (374)
Drug pricing (242)
Drug shortages (35)
Duchenne muscular dystrophy (348)
Earnings (68125)
Editorial (82)
Employer branding (21)
Employer resources (150)
Events (93548)
Executive appointments (1146)
FDA (20972)
Fibrodysplasia Ossificans Progressiva (11)
Friedreich's ataxia (25)
Frontotemporal dementia (37)
Funding (1864)
Gene editing (265)
Generative AI (71)
Gene therapy (831)
GLP-1 (1251)
Government (4514)
Grass and pollen (8)
Guidances (422)
Healthcare (16666)
Hematology (183)
HIV (102)
Huntington's disease (72)
Idiopathic pulmonary fibrosis (1)
IgA nephropathy (127)
Immunology and inflammation (368)
Immuno-oncology (114)
Indications (226)
Infectious disease (3238)
Inflammatory bowel disease (226)
Inflation Reduction Act (14)
Influenza (138)
Intellectual property (329)
Interviews (465)
IPO (14715)
IRA (58)
Job creations (3315)
Job search strategy (1734)
JPM (69)
Kidney cancer (27)
Labor market (116)
Layoffs (666)
Leadership (56)
Legal (7334)
Licensing (11)
Liver cancer (107)
Longevity (34)
Lung cancer (871)
Lymphoma (496)
Machine learning (62)
Management (57)
Manufacturing (1179)
Marketing (13)
MASH (230)
Medical affairs (1)
Medical device (12572)
Medtech (12771)
Mergers & acquisitions (16520)
Metabolic disorders (1828)
mRNA (272)
Multiple sclerosis (193)
NASH (23)
Neurodegenerative disease (522)
Neuropsychiatric disorders (136)
Neuroscience (3784)
Neurotech (2)
NextGen: Class of 2026 (5501)
Non-profit (3911)
Now hiring (46)
Obesity (882)
Opinion (338)
Ovarian cancer (251)
Pain (273)
Pancreatic cancer (372)
Parkinson's disease (414)
Partnered (33)
Patents (673)
Patient recruitment (848)
Peanut (67)
People (50930)
Pharmaceutical (28)
Pharmacy benefit managers (36)
Phase 1 (19781)
Phase 2 (28389)
Phase 3 (22556)
Pipeline (10965)
Policy (400)
Postmarket research (2473)
Preclinical (8270)
Press Release (39)
Prostate cancer (359)
Psychedelics (82)
Radiopharmaceuticals (344)
Rare diseases (1364)
Real estate (4856)
Recruiting (69)
Regulatory (25846)
Reports (54)
Research institute (2612)
Resumes & cover letters (414)
Rett syndrome (51)
RNA editing (27)
RSV (92)
Schizophrenia (198)
Series A (314)
Series B (234)
Service/supplier (7)
Sickle cell disease (129)
Special edition (31)
Spinal muscular atrophy (169)
Sponsored (53)
Startups (3173)
State (1)
Stomach cancer (21)
Supply chain (140)
Tariffs (105)
The Weekly (139)
Vaccines (1297)
Venture capital (148)
Weight loss (607)
Women's health (133)
Worklife (26)
Date
Today (94)
Last 7 days (396)
Last 30 days (2363)
Last 365 days (29636)
2026 (19451)
2025 (29344)
2024 (32838)
2023 (36721)
2022 (47204)
2021 (50889)
2020 (48283)
2019 (39501)
2018 (29943)
2017 (29762)
2016 (28344)
2015 (31256)
2014 (24802)
2013 (20757)
2012 (22125)
2011 (22510)
2010 (20670)
Location
Africa (773)
Alabama (92)
Alaska (6)
Arizona (341)
Arkansas (13)
Asia (36937)
Australia (6586)
California (14146)
Canada (3435)
China (1435)
Colorado (562)
Connecticut (627)
Delaware (442)
Europe (89337)
Florida (2191)
Georgia (439)
Hawaii (5)
Idaho (46)
Illinois (1113)
India (106)
Indiana (573)
Iowa (27)
Japan (632)
Kansas (125)
Kentucky (45)
Louisiana (50)
Maine (85)
Maryland (1702)
Massachusetts (10153)
Michigan (322)
Minnesota (745)
Mississippi (6)
Missouri (157)
Montana (18)
Nebraska (25)
Nevada (148)
New Hampshire (71)
New Jersey (3719)
New Mexico (26)
New York (3721)
North Carolina (1819)
North Dakota (9)
Northern California (7312)
Ohio (422)
Oklahoma (24)
Oregon (37)
Pennsylvania (2664)
Puerto Rico (26)
Rhode Island (37)
South America (1145)
South Carolina (89)
South Dakota (2)
Southern California (5589)
Tennessee (227)
Texas (2266)
United States (49464)
Utah (366)
Vermont (2)
Virginia (349)
Washington D.C. (79)
Washington State (1106)
West Virginia (4)
Wisconsin (150)
Wyoming (2)
623,920 Results for "northwestern memorial s bluhm cardiovascular institute".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Oklahoma Heart Institute Brings New National Cardiovascular Trials and Technologies to Patients Across the Region
August 11, 2026
·
4 min read
Press Releases
Scientists Turn COVID-19 Immune Memory into a Powerful New Ally Against Cancer
Nature Communications Publishes Breakthrough Study Showing How COVID-Era Immune Memory Can Be Redirected to Fight Cancer Celloram, Inc., University Hospitals, and Case Western Reserve University unveil PROTEXI, a novel cancer vaccine platform advancing toward first-in-human clinical trials in sarcoma patients.
July 27, 2026
·
1 min read
Press Releases
Study Reveals How Brain Remodeling During Adolescence Shapes Memory
July 19, 2026
·
6 min read
Cardiovascular disease
Novo’s IL-6 inhibitor fails in cardiovascular Phase 3, plunging shares more than 9%
Novo Nordisk’s IL-6 inhibitor ziltivekimab failed to reduce the risk of cardiovascular events in the late-stage trial, dashing hopes for an edge in the hyper-competitive cardiometabolic space.
July 31, 2026
·
2 min read
·
Michael Gibney
Press Releases
Imricor Launches Imricor Cardiovascular, Opening New U.S. Market for Radiation-Free Cardiac Catheterization
August 3, 2026
·
2 min read
Immunology and inflammation
Novo’s late-stage IL-6 stumble shakes inflammation space
Novo Nordisk was banking on the inflammatory benefits of its investigational therapy ziltivekimab to improve cardiovascular outcomes. Last week’s Phase 3 failure dashed not just the Danish pharma’s hopes but that of other drugmakers working on the same pathway.
August 3, 2026
·
2 min read
·
Tristan Manalac
Press Releases
INmune Bio’s XPro1595 Prevents Brain-Injury-Induced Alzheimer’s Pathology, Memory Loss, and Pain in New Peer-Reviewed Preclinical Study
July 15, 2026
·
6 min read
NextGen
Corsera Eyes Two-Pronged Approach To Tackle Leading Cardiovascular Killer
Corsera Health’s Chief Operating Officer Rena Denoncourt and CFO Meredith Kaya speak with
BioSpace
about the biotech’s mission and vision for the next generation of cardiovascular care.
February 24, 2026
·
2 min read
·
Annalee Armstrong
Press Releases
Feinstein Institutes’ scientists identify the brain’s breathing ‘alarm system’
July 30, 2026
·
3 min read
Collaboration
Lilly Fronts $100M for CSL’s IL-6 Blocker to Bolster I&I, Cardiovascular Pipeline
CSL is advancing clazakizumab for the treatment of cardiovascular events in end-stage kidney disease and will retain rights over the asset in this indication. Lilly will explore other conditions.
February 18, 2026
·
2 min read
·
Tristan Manalac
1 of 62,392
Next
